S
Scandinavian Medical Solutions A/S
CSE:SMSMED
Scandinavian Medical Solutions A/S
CSE:SMSMED
Price:
3.28
DKK
-0.61%
Market Closed
Market Cap:
kr91.2m
Balance Sheet
Balance Sheet Decomposition
Scandinavian Medical Solutions A/S
Scandinavian Medical Solutions A/S
Balance Sheet Decomposition is not available for
Scandinavian Medical Solutions A/S
Scandinavian Medical Solutions A/S
Balance Sheet
Scandinavian Medical Solutions A/S
Scandinavian Medical Solutions A/S
Currency: DKK
| Sep-2020 | Sep-2021 | Sep-2022 | Sep-2023 | Sep-2024 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
11
|
25
|
28
|
8
|
11
|
2
|
|
| Cash Equivalents |
11
|
25
|
28
|
8
|
11
|
2
|
|
| Total Receivables |
3
|
2
|
8
|
21
|
24
|
28
|
|
| Accounts Receivables |
2
|
1
|
7
|
15
|
21
|
23
|
|
| Other Receivables |
0
|
1
|
1
|
6
|
3
|
5
|
|
| Inventory |
4
|
16
|
56
|
86
|
85
|
110
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
1
|
2
|
|
| Total Current Assets |
17
|
44
|
93
|
115
|
121
|
142
|
|
| PP&E Net |
0
|
0
|
13
|
48
|
52
|
63
|
|
| Long-Term Investments |
0
|
0
|
0
|
1
|
1
|
1
|
|
| Total Assets |
17
N/A
|
45
+162%
|
106
+138%
|
164
+55%
|
174
+6%
|
206
+18%
|
|
| Liabilities | |||||||
| Accounts Payable |
8
|
7
|
25
|
34
|
41
|
50
|
|
| Short-Term Debt |
0
|
0
|
0
|
7
|
22
|
27
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
3
|
4
|
7
|
|
| Other Current Liabilities |
4
|
13
|
15
|
27
|
11
|
8
|
|
| Total Current Liabilities |
12
|
21
|
40
|
72
|
77
|
91
|
|
| Long-Term Debt |
0
|
0
|
0
|
18
|
13
|
30
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
1
|
2
|
|
| Other Liabilities |
0
|
0
|
4
|
0
|
0
|
0
|
|
| Total Liabilities |
12
N/A
|
21
+69%
|
44
+114%
|
90
+104%
|
92
+2%
|
123
+34%
|
|
| Equity | |||||||
| Common Stock |
0
|
1
|
1
|
1
|
1
|
1
|
|
| Retained Earnings |
5
|
23
|
61
|
73
|
81
|
82
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
5
N/A
|
24
+394%
|
62
+158%
|
74
+20%
|
82
+11%
|
83
+0%
|
|
| Total Liabilities & Equity |
17
N/A
|
45
+162%
|
106
+138%
|
164
+55%
|
174
+6%
|
206
+18%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
27
|
27
|
27
|
27
|
28
|
28
|
|
Switch to:
Switch to:
See Also
Discover More
